AllianceBernstein’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.87M Buy
31,929
+400
+1% +$106K ﹤0.01% 1324
2025
Q4
$7.77M Buy
31,529
+1,609
+5% +$339K ﹤0.01% 1343
2025
Q3
$5.28M Sell
29,920
-1,200
-4% -$180K ﹤0.01% 1497
2025
Q2
$4.28M Hold
31,120
﹤0.01% 1544
2025
Q1
$5.61M Hold
31,120
﹤0.01% 1410
2024
Q4
$4.88M Buy
31,120
+1,400
+5% +$248K ﹤0.01% 1499
2024
Q3
$5.41M Hold
29,720
﹤0.01% 1488
2024
Q2
$5.46M Buy
29,720
+5,960
+25% +$1M ﹤0.01% 1456
2024
Q1
$4.23M Sell
23,760
-2,140
-8% -$297K ﹤0.01% 1529
2023
Q4
$3.21M Hold
25,900
﹤0.01% 1696
2023
Q3
$3M Sell
25,900
-200
-0.8% -$24.4K ﹤0.01% 1658
2023
Q2
$3.06M Hold
26,100
﹤0.01% 1663
2023
Q1
$2.09M Hold
26,100
﹤0.01% 1845
2022
Q4
$2.07M Buy
26,100
+600
+2% +$44.5K ﹤0.01% 1900
2022
Q3
$1.78M Hold
25,500
﹤0.01% 1959
2022
Q2
$1.67M Buy
25,500
+2,100
+9% +$131K ﹤0.01% 2055
2022
Q1
$1.56M Buy
23,400
+2,700
+13% +$169K ﹤0.01% 2230
2021
Q4
$1.45M Hold
20,700
﹤0.01% 2321
2021
Q3
$1.08M Hold
20,700
﹤0.01% 2464
2021
Q2
$1.41M Buy
20,700
+7,100
+52% +$496K ﹤0.01% 2379
2021
Q1
$1.05M Buy
13,600
+300
+2% +$21.8K ﹤0.01% 2394
2020
Q4
$798K Hold
13,300
﹤0.01% 2398
2020
Q3
$573K Sell
13,300
-700
-5% -$30.4K ﹤0.01% 2463
2020
Q2
$580K Buy
14,000
+2,600
+23% +$125K ﹤0.01% 2509
2020
Q1
$493K Sell
11,400
-600
-5% -$31.4K ﹤0.01% 2364
2019
Q4
$665K Buy
12,000
+2,700
+29% +$132K ﹤0.01% 2431
2019
Q3
$323K Buy
9,300
+1,200
+15% +$53.6K ﹤0.01% 2777
2019
Q2
$326K Buy
+8,100
New +$265K ﹤0.01% 2795

Other funds holding KRYS